Results for tag: "Dulera"

The Dulera market is a segment of the respiratory drug market that focuses on the treatment of asthma and chronic obstructive pulmonary disease (COPD). Dulera is a combination of two drugs, mometasone and formoterol, which work together to reduce inflammation and open up the airways. It is used to treat symptoms such as shortness of breath, wheezing, and chest tightness. Dulera is available in both an inhaler and a nebulizer, and is typically prescribed for long-term use. The Dulera market is highly competitive, with many companies offering similar products. Some of the major players in the market include GlaxoSmithKline, Merck, Novartis, and Teva Pharmaceuticals. Other companies such as Mylan, Sunovion, and Boehringer Ingelheim also offer Dulera products. Show Less Read more